Marcus M. Reidenberg
#126,923
Most Influential Person Now
Marcus M. Reidenberg's AcademicInfluence.com Rankings
Marcus M. Reidenberglaw Degrees
Law
#2312
World Rank
#2887
Historical Rank
International Law
#450
World Rank
#565
Historical Rank
Marcus M. Reidenbergphilosophy Degrees
Philosophy
#5982
World Rank
#8933
Historical Rank
Logic
#3185
World Rank
#4305
Historical Rank
Download Badge
Law Philosophy
Marcus M. Reidenberg's Degrees
- Doctorate Law Columbia University
- Bachelors Economics Dartmouth College
Similar Degrees You Can Earn
Why Is Marcus M. Reidenberg Influential?
(Suggest an Edit or Addition)Marcus M. Reidenberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Central nervous system excitatory effects of meperidine in cancer patients (1983) (379)
- Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. (1978) (350)
- The selection and use of essential medicines. (2009) (346)
- Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. (1977) (346)
- Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. (1971) (324)
- Adverse nondrug reactions. (1968) (229)
- Relationship between diazepam dose, plasma level, age, and central nervous system depression (1978) (207)
- Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial (2001) (202)
- Polymorphic acetylation of procainamide in man (1975) (198)
- Quinidine elimination in patients with congestive heart failure or poor renal function. (1974) (172)
- Barriers to better pain control in hospitalized patients. (1999) (163)
- INFLUENCE OF DISEASE ON BINDING OF DRUGS TO PLASMA PROTEINS * (1973) (162)
- The selection and use of essential medicines. (2014) (162)
- Oral gossypol in the treatment of metastatic adrenal cancer. (1993) (161)
- The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species (1972) (156)
- Clinical consequences of polymorphic acetylation of basic drugs (1977) (150)
- Phenytoin in the treatment of diabetic symmetrical polyneuropathy (1977) (146)
- Hydralazine elimination in man (1973) (132)
- The biotransformation of drugs in renal failure. (1977) (124)
- The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. (1977) (123)
- Gossypol Treatment of Recurrent Adult Malignant Gliomas (1999) (113)
- Metabolic changes associated with the cessation of cigarette smoking. (1970) (112)
- Alteration of Drug-Protein Binding in Renal Disease (1984) (107)
- Positive direct Coombs tests due to cephalothin. (1967) (98)
- Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. (1984) (97)
- Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology. (2010) (94)
- Renal Function and Drug Action (1971) (92)
- N-Acetylprocainamide: An Active Metabolite of Procainamide 1 (1974) (90)
- Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. (1979) (87)
- The Binding of Drugs to Plasma Proteins from Patients with Poor Renal Function (1976) (83)
- Cumulation of N‐acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function (1977) (83)
- Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. (1983) (79)
- N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease. (1983) (78)
- Stereoselective renal tubular secretion of quinidine and quinine (1986) (75)
- Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. (1993) (73)
- Optimizing metoclopramide control of cisplatin-induced emesis. (1984) (73)
- Aging and renal clearance of procainamide and acetylprocainamide (1980) (73)
- The acetylator phenotype of patients with systemic lupus erythematosus. (1974) (72)
- Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study. (2000) (69)
- Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. (1997) (68)
- 1991 Annual report (1992) (67)
- Physicians being deceived. (2007) (67)
- Pruritus in dialysis patients treated with parenteral lidocaine. (1977) (67)
- Drug Discontinuation Effects Are Part of the Pharmacology of a Drug (2011) (65)
- Aromatic amines and the pathogenesis of lupus erythematosus. (1983) (60)
- Breast silicone implants and risk of systemic lupus erythematosus. (1994) (60)
- Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages (1983) (57)
- Grapefruit juice and its flavonoids inhibit 11β‐hydroxysteroid dehydrogenase (1996) (56)
- Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. (1994) (56)
- Rate of drug metabolism in obese volunteers before and during starvation and in azotemic patients. (1969) (55)
- Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome. (1981) (55)
- Lupus erythematosus-like disease due to hydrazine. (1983) (54)
- The rate of procaine hydrolysis in serum of normal subjects and diseased patients (1972) (54)
- Acetylator phenotype in idiopathic systemic lupus erythematosus. (1980) (52)
- Propylthiouracil-induced immune-mediated disease in the cat. (1985) (51)
- A Method for Measuring Naringenin in Biological Fluids and Its Disposition from Grapefruit Juice by Man (1998) (49)
- Different Pathways of Cell Killing by Gossypol Enantiomers (2002) (48)
- Treatment of Urinary Incontinence with Anticholinergics in Patients taking Cholinesterase Inhibitors for Dementia (2004) (48)
- Measurement of Urinary Clusterin as an Index of Nephrotoxicity (1992) (48)
- The response of bone to metabolic acidosis in man. (1966) (47)
- Reversible, narcotic-associated mental status impairment in patients with metastatic cancer. (1987) (47)
- Pentobarbital elimination in patients with poor renal function (1976) (44)
- Low-dose theophylline therapy in idiopathic apnea of prematurity. (1980) (42)
- Unaltered metabolism of antipyrine and tolbutamide in fasting man (1975) (41)
- In vitro response of rat and human kidney lysosomes to aminoglycosides. (1982) (41)
- Prosecution of Physicians for Prescribing Opioids to Patients (2007) (40)
- Inhibition of 11 beta-hydroxysteroid dehydrogenase by gossypol and bioflavonoids. (1992) (40)
- Chronic morphine administration: Plasma levels and withdrawal syndrome in rats (1976) (38)
- Alterations in state in apneic pre‐term infants receiving theophylline (1978) (38)
- Ventilation-perfusion relationships in the obese patient. (1969) (36)
- The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias. (1980) (36)
- Counterfeit and substandard drugs (2001) (35)
- The risk of disciplinary action by state medical boards against physicians prescribing opioids. (2005) (35)
- Effect of disease states on plasma protein binding of drugs. (1974) (34)
- Effect of the requirement for triplicate prescriptions for benzodiazepines in New York State (1991) (34)
- Grand mal seizure in a child 30 minutes after Cyclogyl (cyclopentolate hydrochloride) and 10% Neo-Synephrine (phenylephrine hydrochloride) eye drops were instilled. (2004) (33)
- Differences in serum potassium concentrations in normal men in different geographic locations. (1993) (33)
- Inhibition of 11β-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furoemide, naringenin and some other compounds (1994) (30)
- The chemical induction of systemic lupus erythematosus and lupus-like illnesses. (1981) (30)
- Urinary Clusterin in Chronic Nephrotoxicity in the Rat (1993) (29)
- Elimination of isoniazid in patients with impaired renal function. (1973) (28)
- The risk of action by the Drug Enforcement Administration against physicians prescribing opioids for pain. (2006) (27)
- In vitro acetylation of drugs by human blood cells. (1974) (27)
- ALDOSTERONE, 17-HYDROXYCORTICOSTEROID, 17-KETOSTEROID, AND FLUID AND ELECTROLYTE RESPONSES TO STARVATION AND SELECTIVE REFEEDING (1967) (27)
- Inhibitory effects of gossypol on corticosteroid 11β-hydroxysteroid dehydrogenase from guinea pig kidney: A possible mechanism for causing hypokalemia (1991) (27)
- Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography. (1977) (26)
- Dose-dependent induction of anti-native DNA antibodies in cats by propylthiouracil. (1988) (26)
- Long-term antiarrhythmic therapy with acetylprocainamide. (1981) (26)
- The need for an open mind about the treatment of chronic nonmalignant pain (1994) (25)
- Drug-protein binding. (1973) (25)
- Drugs in the elderly. (1980) (25)
- Protecting Patients, Preserving Integrity, Advancing Health : Accelerating the Implimentation of COI Policies in Human Subjects Research (2008) (25)
- Obesity and fasting—effects on drug metabolism and drug action in man (1977) (25)
- Kidney disease and drug metabolism. (1974) (24)
- Potential artifacts in the use of caffeine to determine acetylation phenotype. (1989) (24)
- Drug therapy in renal failure. (1980) (23)
- Pharmacokinetics of essential amino acids in chronic dialysis-patients. (1978) (22)
- Development of antinuclear antibody in patients treated with high doses of captopril. (1984) (22)
- Hemodynamic changes in adrenalectomized dogs. (1963) (22)
- Removal of mercury by peritoneal dialysis. (1974) (22)
- Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum. (1981) (22)
- Effects of renal disease upon drug disposition. (1978) (22)
- World Health Organization Program for the Selection and Use of Essential Medicines (2007) (21)
- Inhibition of 11beta-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol. (1998) (21)
- A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen. (1987) (21)
- Further studies of the response of kidney lysosomes to aminoglycosides and other cations. (1983) (21)
- The discipline of clinical pharmacology (1985) (21)
- Pain control and the World Health Organization analgesic ladder. (1996) (20)
- The protein binding of some drugs in plasma from patients with alcoholic liver disease (1975) (20)
- Clinical pharmacology: The scientific basis of therapeutics (1999) (19)
- Evaluating Patients’ Warfarin Requirements (1980) (19)
- Alzheimer's disease and Down's syndrome: treating two paths to dementia. (2013) (19)
- Environmental inhibition of 11β-hydroxysteroid dehydrogenase (2000) (19)
- Propoxyphene (Darvon) addiction and withdrawal syndrome. (1969) (19)
- Evolving ways that drug therapy is individualized (2003) (18)
- Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase. (1996) (18)
- The noninterference of aluminum hydroxide gel with quinidine sulfate absorption: an approach to control quinidine-induced diarrhea. (1978) (18)
- Increased Urinary Enzyme Excretion in Workers Exposed to Nephrotoxic Chemicals (1985) (16)
- Statins for primary prevention of coronary artery disease (2007) (16)
- Slight renal effect of mercury from amalgam fillings. (1995) (16)
- Determination of gossypol enantiomers in plasma after administration of racemate using high-performance liquid chromatography with precolumn chemical derivatisation. (1988) (16)
- Lipophilic beta-blockers inhibit rat skeletal muscle mitochondrial respiration. (1993) (15)
- Assessment of patients' pain. (1996) (15)
- Symptomatic hypokalemia resulting from surreptitious diuretic ingestion. (1981) (14)
- Kidney function and drug action. (1985) (14)
- Vitamin D and Calcium Supplementation to Prevent Fractures in Adults (2013) (14)
- Drug therapy in the elderly: The problem from the point of view of a clinical pharmacologist (1987) (13)
- Essential Medicines for the Whole World (2007) (13)
- Statins, lack of energy and ubiquinone. (2005) (12)
- ACUTE RENAL FAILURE DUE TO NEPHROTOXINS (1964) (12)
- Microsomal hydroxylation as measured by pentobarbital elimination in patients with idiopathic systemic lupus erythematosus (1982) (12)
- Drug Interactions and the Elderly (1982) (12)
- Decreasing publication bias (1998) (12)
- Morphine concentrations in the rat after intraperitoneal or subcutaneous injection. (1980) (12)
- Serum Digoxin Concentration and Age * (1980) (11)
- Are drugs for rare diseases "essential"? (2006) (11)
- The quality of clinical research (1990) (11)
- Cigarette Smoking, Coffee Drinking, and Ingestion of Charcoal-Broiled Beef as Potential Modifiers of Drug Therapy and Confounders of Clinical Trials (2012) (11)
- Metabolism of tetralin and toxicity of Cuprex in man. (1973) (11)
- Centers for Education and Research in Therapeutics (2000) (10)
- The teaching of clinical pharmacology in Europe and North America. (1989) (10)
- Symposium on drug action and metabolism in renal failure: foreword. (1977) (10)
- Drug labeling should be kept current (2003) (10)
- Essential amino acid metabolism in maintenance dialysis patients. (1976) (9)
- Drugs in the elderly. (1980) (9)
- Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics. (1995) (9)
- Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol. (2002) (9)
- Increased renal tubular cell excretion by patients receiving chronic therapy with gold and with nonsteroidal anti‐inflammatory drugs (1989) (9)
- Lack of effect of glutathione depletion by L-buthionine-S,R-sulfoximine on gentamicin nephrotoxicity in rats. (1990) (9)
- Barriers to controlling pain in patients with cancer (1996) (8)
- What has been the impact of the concept of essential drugs? (2003) (8)
- The Procaine Esterase Activity of Serum from Different Mammalian Species 1 (1972) (8)
- Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia. (2015) (8)
- EFFECT OF STEROID HORMONES ON THE PARATHYROID HORMONE DOSE-RESPONSE CIJRVE (1969) (8)
- Cardiovascular Responses to Norepinephrine in Acute Adrenal Insufficiency.∗ (1958) (8)
- The pros and cons of essential medicines for rich countries (2004) (7)
- Dietary fatty acids are also drugs (1994) (7)
- Stereoselective interaction between gossypol and rat plasma. (1990) (7)
- Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups. (1985) (7)
- The drug-approval process. (1988) (7)
- Publication and proprietary information (1996) (7)
- Are we treating health or physical appearance when we prescribe drugs for obesity? (2000) (6)
- Mechanisms of blood pressure control in anephrics: plasma renin and dopamine beta hydroxylase activity. (1976) (6)
- Acute effects of vasodilators on left-to-right shunts in infants and children. (1981) (6)
- Conflict of interest and medical publication (2002) (6)
- Serum potassium: values in normal men in Shanghai vs those in men from Shanghai living abroad. (1994) (6)
- Tang and methadone by vein. (1972) (6)
- Aromatic amines and hydrazines drug acetylation, and lupus erythematodes. (1978) (6)
- Trends in Clinical Pharmacokinetics (1993) (6)
- Cyclophosphamide dose in renal failure (1978) (6)
- Should unevaluated therapies be available for sale? (1987) (5)
- Essential drugs and the WHO Model List: Addressing new issues (1996) (5)
- Antiarrhythmic activity of p-hydroxy-N-(2-diethylaminoethyl) benzamide (the p-hydroxy isostere of procainamide) in dogs and mice. (1977) (5)
- 2507 – CLINICAL PHARMACOLOGY OF N-ACETYLPROCAINAMIDE (NAPA), THE MAJOR METABOLITE OF PROCAINAMIDE IN MAN (1978) (5)
- Improving how we evaluate the toxicity of approved drugs (2006) (5)
- Effect of adrenal medullectomy and total adrenalectomy on the hemodynamic responses to tyramine. (1968) (5)
- Drugs in the elderly. (1982) (5)
- Lymphocyte transformation tests and suspected drug allergy. (1975) (5)
- Clinical trials report card. (2006) (4)
- NAD- and NADP-dependent 11 beta-hydroxysteroid dehydrogenase isoforms in guinea pig kidney with gossypol inhibition. (1997) (4)
- The state of drug development in the united states in 1990: A view from the academic community (1990) (4)
- Adverse drug reactions without drugs. (1967) (4)
- Essential drugs and WHO Model List: addressing new issues. Report of a workshop focusing on the report of the World Health Organization Expert Committee on the Use of Essential Drugs. (1996) (4)
- Some smokers lie (1994) (4)
- Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent. (1979) (4)
- Kinetics of metoprine, a lipid-soluble antifolate. (1981) (4)
- Attitudes about clinical research (1996) (4)
- Informed consent or acknowledgment of disclosure (2005) (4)
- Drug metabolism and active drug metabolites in renal failure. (1977) (4)
- Hemodynamic effects of adrenal medullectomy in the dog. (1966) (4)
- U.S. basic research: delayed drug development. (2012) (4)
- Thoughts from the Editor (2002) (3)
- The Pinocchio factor (1994) (3)
- An open invitation for an explanation about how drug prices are set (2001) (3)
- Environmental inhibition of 11beta-hydroxysteroid dehydrogenase. (2000) (3)
- Clinical Pharmacology and the Aged Patient (1982) (3)
- Criteria for judging proposals for national health care reform with respect to therapeutics (1994) (3)
- Factors that modify drug absorption. (1978) (3)
- A case of apparent photosensitization due to pyrvinium pamoate. (1962) (3)
- Early Research on Renal Function and Drug Action (2012) (3)
- Comparison of Antiarrhythmic Effects of Procainamide, N-Acetylprocainamide, and p-Hydroxy-N-(3-diethylaminopropyl)benzamide (1982) (3)
- The binding of theophylline to serum proteins of hemodialysis patients. (1979) (3)
- The Pharmacogenetics of Antiarrhythmic Drugs (1984) (3)
- Unusual cause of theophylline toxicity. (1979) (3)
- Effect of steroid hormones on the parathyroid hormone dose-response curve. (1969) (3)
- SOME EXTRANEURONAL INTERACTIONS OF DRUGS OF ABUSE: AN OVERVIEW (1976) (3)
- CLINICAL EXPERIENCES WITH BRETYLIUM TOSYLATE (1960) (3)
- Certifying physicians in clinical pharmacology (1988) (3)
- Issues in Developing the Medical Scientist, Part 3: Evaluation of Scientific Achievement (Essay by and Interview with Marcus M. Reidenberg, MD) (2004) (3)
- Procainamide, N-Acetylprocainamide, Antinuclear Antibody and Systemic Lupus Erythomatosus (1986) (2)
- Sponsorship, authorship and accountability. (2002) (2)
- Effect of thyroparathyroidectomy on skeletal sodium metabolism in the rat. (1969) (2)
- Letter: Stability of aspirin in propoxyphene compound dosage forms. (1974) (2)
- A plea for prices in physician prescribing. (1991) (2)
- Letter: Slow extrarenal excretion of digoxin. (1973) (2)
- Gossypol and Na+, K+ ATPase from human erythrocytes. (1988) (2)
- Polymorphic Drug Acetylation and Systemic Lupus Erythematosus (1979) (2)
- The role of bone in electrolyte metabolism. (1961) (2)
- Accumulation of polyamines and their weak association with lower body temperature in elderly convalescent patients. (1987) (2)
- The effect of vitamin B6 deficiency on acetylhydrazine hepatic necrosis. (1994) (2)
- What should authors expect from the reviewers and the editors of Clinical Pharmacology & Therapeutics? (1997) (2)
- Low-dose theophylline of prematurity therapy in idiopathic apnea (1980) (2)
- 314 – PLASMA CONCENTRATION AND RENAL CLEARANCE OF PROCAINAMIDE (PA) AND ITS ACETYLATED METABOLITE IN MAN (1977) (2)
- Drugs and the liver (1998) (2)
- Metoclopramide and chemotherapy-induced emesis. (1984) (2)
- Drug metabolism in uremia. (1975) (1)
- New headings for the Table of Contents (1999) (1)
- Notes of the American Society for Clinical Pharmacology and Therapeutics (1984) (1)
- Should Administration of Coenzyme Q10 Be Recommended to Patients with Congestive Heart Failure? (2014) (1)
- Principles of drug dosing in renal failure (1998) (1)
- Effect of Adrenocortical Steroids on Bone Electrolyte Metabolism.∗ (1961) (1)
- Clinical pharmacology. (1993) (1)
- Effect of potassium deficiency and gossypol on urinary N-acetyl-beta-glucosaminidase excretion in the rat. (1993) (1)
- Reply: Rejecting a double standard for scientific publication (1989) (1)
- Pharmacological aspects of nephrotoxicity (2003) (1)
- CHAPTER 5 – Effects of Renal Disease on Pharmacokinetics (2007) (1)
- Are clinical research grant applications reviewed fairly? (1994) (1)
- The history of Clinical Pharmacology & Therapeutics. (1990) (1)
- Are we moving towards a new definition of essential medicines? (2015) (1)
- Adverse drug reactions: special cases of chemically-induced diseases (1979) (1)
- Book ReviewDrug Treatment: Principles and practice of clinical pharmacology and therapeutics Handbook of Drug Therapy (1980) (1)
- Adverse drug reactions: further controversy. (1976) (1)
- Clinical Pharmacology & Therapeutics Annual report 2000 (2001) (1)
- From Adverse Drug Reactions to Drug Disposition to WHO and Essential Medicines to Our Discipline of Clinical Pharmacology (2010) (1)
- A case of lupus erythematosus-like illness due to hydrazine (1981) (1)
- The history of CLINICAL PHARMACOLOGY & THERAPEUTICS (1990) (1)
- Note from the editor (1996) (1)
- Diagnosis Drift and Its Contribution to Polypharmacy (2018) (1)
- Decision Making in Drug Research.Franz Gross (1985) (0)
- The clinical pharmacology of biotechnology products : proceedings of the Esteve Foundation Symposium IV, Son Vida, Mallorca, 7-10 October 1990 (1991) (0)
- 1986 Annual Report to the Editorial Advisory Committee (1987) (0)
- Book ReviewProgress in Biochemical Pharmacology. (1973) (0)
- Sponsorship, authorship, and accountability. (2001) (0)
- Comment (1998) (0)
- Cyanocobalamin--a case for withdrawal. (1993) (0)
- CLINICAL PHARMACOLOGY (2010) (0)
- LiquidChromatographyand FluorescenceSpectroscopyComparedwith a HomogeneousEnzymeImmunoassayTechniquefor DeterminingQuinidine in Serum (2004) (0)
- Referees for volume 28 (2004) (0)
- Effects ofHydralazine on Coronary BloodFlowand Myocardial Energetics inCongestive HeartFailure (1982) (0)
- Reply (2004) (0)
- Book ReviewClinical Management of Poisoning and Drug Overdose (1983) (0)
- Clinical pharmacology and therapeutics: new directions?: Third World Conference on Clinical Pharmacology and Therapeutics, Stockholm, Sweden, July 27–August 1, 1986 (1986) (0)
- Reply (1988) (0)
- Treatment of mice with tyrosine kinase inhibitors (TKI) such as Gleevec lowers plasma levels of amyloid beta peptides (Abeta) in mice (2011) (0)
- N-acetyl-ß-glucosaminidase and ß2-Microglobulin in Renal Disease-Reply (1984) (0)
- Notes of the American Society for Clinical Pharmacology and Therapeutics (1985) (0)
- Response to “The Need for Clinical Pharmacology Is Greater Than Ever” (2008) (0)
- Thank you to the Reidenbergs (2002) (0)
- [The present state of knowledge on the treatment of peptic diseases with cimetidine]. (1981) (0)
- A Note from the Co‐Editor (1985) (0)
- Changing digitalis glycosides in an average-size adult (1977) (0)
- Drug Metabolism and Dose Adjustment in Patients with Renal Failure (1981) (0)
- Adaptation to Nephrotoxic Chemicals (4281 6) (1988) (0)
- Statins for Primary Prevention in Adults Aged 75 Years or Older. (2015) (0)
- CLINICAL PHARMACOLOGY (1991) (0)
- Summary of the Report of the Joint Commission on Prescription Drug Use, Inc. (1981) (0)
- Toxicology of the Kidney (1982) (0)
- Annual Report 1999 (2000) (0)
- Clearance of dopamine in children is related to age (1990) (0)
- Gift subscriptions to medical libraries in least‐developed countries (1986) (0)
- Drug Shortages in the U.S. and the World: A Public Forum (2012) (0)
- Reply to Editorial and Comments (2007) (0)
- The selection and use of essential medicines. (2004) (0)
- Introduction to Symposium on Cardiac Glycosides (1986) (0)
- Walter Modell, MD, 1907–1990 (1991) (0)
- Error dependent on renal function when monoexponential equation assumed (1978) (0)
- Health care and patient services. (1986) (0)
- Clinical pharmacology. (1995) (0)
- The selection and use of essential medicines. (2008) (0)
- Book ReviewNeurotoxins in Clinical Practice (1986) (0)
- Current status of cimetidine in acid-peptic disorders. (1981) (0)
- Dopamine and blood flow. (1977) (0)
- Use of opioids in management of chronic noncancer pain. (2010) (0)
- Patient compliance, patient education and ego defense. (1975) (0)
- ANTIARRHYTHMIC ACTIVITY OF P-HYDROXY-N-(2-DIETHYLAMINOETHYL)BENZAMIDE (THE P-HYDROXY ISOSTERE OF PROCAINAMIDE) IN DOGS AND MICE (1977) (0)
- A note from the Co‐Editor (1985) (0)
- Note from the Editor (1997) (0)
- The ventricular activity of some analogs of procainamide (PA) on the isolated guinea pig heart (1975) (0)
- Report on workshop on the development of drugs to be used in the elderly (1984) (0)
- DOSE INTERVALS FOR PROCAINAMIDE (1975) (0)
- Erratum: Dietary fatty acids are also drugs (Clinical Pharmacology and Therapeutics (1994) 55 (5-9)) (1994) (0)
- Rational prescribing of essential medicines (2003) (0)
- Letter from Marcus M. Reidenberg to Joshua Lederberg (1980) (0)
- Lack of Transparency in Emergency Care (2013) (0)
- A paradox of informed consent. (1975) (0)
- Environmental factors in renal disease. (1981) (0)
- Comment About the Three Commentaries (2006) (0)
- Book Review:Drug Disposition in Humans: The Basis of Clinical Pharmacology. William A. Creasey (1980) (0)
- The selection and use of essential medicines. (2007) (0)
- 550 – POLYMORPHIC DRUG ACETYLATION AND SYSTEMIC LUPUS ERYTHEMATOSUS (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marcus M. Reidenberg?
Marcus M. Reidenberg is affiliated with the following schools:
